Literature DB >> 11462153

Mechanism of growth inhibitory effect of Mitomycin-C on cultured human retinal pigment epithelial cells: apoptosis and cell cycle arrest.

S G Kang1, H Chung, Y D Yoo, J G Lee, Y I Choi, Y S Yu.   

Abstract

PURPOSE: To investigate the therapeutic potential of Mitomycin-C (MMC) in the management of proliferative vitreoretinopathy, the antiproliferative effect of MMC on cultured human retinal pigment epithelial (RPE) cells were investigated in vitro.
METHODS: Drug sensitivities of cultured human RPE cells to MMC were determined using the tetrazolium dye assay. In order to detect the presence of apoptosis, DNA fragmentation was assessed by DAPI staining, and TdT-dUTP nick-end labeling (TUNEL) assay. The relative amount of DNA fragmentation was quantified by flow cytometric analysis. To analyze the cell cycle response of RPE cells to MMC, flow cytometric analysis of propidium iodide stained nuclei was performed. The levels of proteins related to DNA damage in the RPE cells were then determined by Western blot analysis.
RESULTS: MMC inhibited cell proliferation in a dose-dependent manner. The majority of RPE cells following treatment with 10 microg/ml of MMC exhibited fragmented nuclei as observed by DAPI staining and TUNEL assay. Cell cycle analysis demonstrated an accumulation of cells arrested in S and G2/M phase following treatment with 1 microg/ml of MMC. At 10 microg/ml of MMC, a dramatic increase of the cell population in the sub G1 peak, which can be considered a marker of cell death by apoptosis, was observed by flow cytometry. Western blot analysis of p53 and p21 revealed a gradual increase in the level of these proteins when RPE cells were exposed to increasing concentrations of MMC.
CONCLUSIONS: This study demonstrated that the response of RPE cells to MMC was bi-directional: 1) partial arrest of the cell cycle at S, G2/M phase, and 2) induction of apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462153     DOI: 10.1076/ceyr.22.3.174.5513

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  19 in total

1.  Efficacy and safety of mitomycin C as an agent to treat corneal scarring in horses using an in vitro model.

Authors:  Dylan G Buss; Ajay Sharma; Elizabeth A Giuliano; Rajiv R Mohan
Journal:  Vet Ophthalmol       Date:  2010-07       Impact factor: 1.644

2.  Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo.

Authors:  Qian-mei Zhou; Xiu-feng Wang; Xin-jun Liu; Hui Zhang; Yi-yu Lu; Shi-bing Su
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

3.  Invadopodia-mediated ECM degradation is enhanced in the G1 phase of the cell cycle.

Authors:  Battuya Bayarmagnai; Louisiane Perrin; Kamyar Esmaeili Pourfarhangi; Xavier Graña; Erkan Tüzel; Bojana Gligorijevic
Journal:  J Cell Sci       Date:  2019-10-18       Impact factor: 5.285

4.  Repositioning "old" drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion.

Authors:  Esha T Shah; Akanksha Upadhyaya; Lisa K Philp; Tiffany Tang; Dubravka Skalamera; Jennifer Gunter; Colleen C Nelson; Elizabeth D Williams; Brett G Hollier
Journal:  Clin Exp Metastasis       Date:  2016-03-01       Impact factor: 5.150

5.  Distinct cellular phenotype linked to defective DNA interstrand crosslink repair and homologous recombination.

Authors:  Aleksandra M Gorniewska; Katarzyna Kluzek; Lidia Gackowska; Izabela Kubiszewska; Malgorzata Z Zdzienicka; Aneta Bialkowska
Journal:  Mol Med Rep       Date:  2017-06-15       Impact factor: 2.952

6.  Mitomycin C: a promising agent for the treatment of canine corneal scarring.

Authors:  Rangan Gupta; Benjamin W Yarnall; Elizabeth A Giuliano; Jagat R Kanwar; Dylan G Buss; Rajiv R Mohan
Journal:  Vet Ophthalmol       Date:  2011-04-18       Impact factor: 1.644

7.  Impaired mitotic progression and preimplantation lethality in mice lacking OMCG1, a new evolutionarily conserved nuclear protein.

Authors:  Jérôme Artus; Sandrine Vandormael-Pournin; Morten Frödin; Karim Nacerddine; Charles Babinet; Michel Cohen-Tannoudji
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

8.  Intraocular application of Mitomycin C to prevent proliferative vitreoretinopathy in perforating and severe intraocular foreign body injuries.

Authors:  Alexandre Assi; Ziad Khoueir; Charles Helou; Henry Fakhoury; Georges Cherfan
Journal:  Eye (Lond)       Date:  2019-03-27       Impact factor: 3.775

9.  Inhibitory and Apoptotic Effects of Mannan-Mitomycin C Conjugate Against Transitional Cell Carcinoma and Normal Mouse Fibroblasts.

Authors:  Ladan Kabiri; Shiva Irani; Amin Reza Nikpoor; Jalil Tavakkol Afshari
Journal:  Rep Biochem Mol Biol       Date:  2019-04

10.  Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits.

Authors:  Marcelo V Netto; Rajiv R Mohan; Sunilima Sinha; Ajay Sharma; Pankaj C Gupta; Steven E Wilson
Journal:  J Refract Surg       Date:  2006-06       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.